openPR Logo
Press release

Reperfusion Injury Market 2016-2024 Growth and Forecast

08-04-2017 05:07 PM CET | Health & Medicine

Press release from: Transparency Market Research

Reperfusion Injury Market: Description

Reperfusion injury is referred to as the tissue damage caused due to absence of blood supply or lack of oxygen such as damage to brain after stroke or heart post episodes of ischemia. Such kind of restoration of blood supply results into inflammation and oxidative damage through the induction of oxidative stress rather than normal functioning. Confined infarct size and reduced mortality can be achieved by prompt restoration of blood supply to myocardium. However, this restoration is also known to result in the cardiac damage and eventually reperfusion injury. A delay in reperfusion therapy has been attributed for such damage. 

View Report @ http://www.transparencymarketresearch.com/reperfusion-injury-market.html

Reperfusion of ischemic tissue is often associated with microvascular injury. The duration for which a tissue can survive deprived of oxygen varies, but eventually the tissue is rendered necrotic. The blood supply restoration usually minimizes the damage, but reperfusion of tissue post thrombolytic procedures demonstrated that the extent of injury often increased on restoration of the blood supply. The studies have also attributed this reperfusion injury, to the activity of free radicals.

Reperfusion Injury Market: Segmentation

The global reperfusion injury market can be segmented based on therapy type, injury type and geography. Drugs used for treating reperfusion injury are classified on the basis of mode of action, target site, route of administration and molecule type. Geographically, the global reperfusion injury market can be categorized into four major regions namely, North America, Europe, Asia-Pacific and Rest of the World. Primary percutaneous coronary intervention (PCI) and thrombolysis, form the primary reperfusion therapies and are often used for treating acute coronary syndromes.

Reperfusion Injury Market: Overview

Allopurinol, one of the drugs in clinical trials helps inhibit production of free radicals thereby known to reduce the size of infarct. However the drug has not been universally successful. An enzyme called recombinant superoxide dismutase has been under investigation as free radical scavenger that detoxifies oxygen. Various other drug molecules in clinical trials include cyclosporine, MTP-131, bucillamine, recombinant proteins, type 5 adenylyl cyclase inhibitors, and synthetic peptides amongst others. Agents that specifically target proteins, transcription factors or ion channels, including PPAR, PKC agonists/antagonists, Phosphodiesterase-5 inhibitors, the ATP-dependent potassium channel and 3-Hydroxy-3-methyl glutaryl coenzyme A reductase are also promising.

Get accurate market forecast and analysis on the Reperfusion Injury Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15710

However, currently no agent has been clinically approved for treatment of reperfusion injury. Studies demonstrating success in the clinical use have been disappointing for last few years though successful results have been observed on animals. The unclear solutions and lesser potential therapies that limit the free radicals generation on reperfusion are also under investigation in several clinical trials. New avenues for investigation are recently opened due to studies demonstrating involvement of inflammatory cytokines and their effects on neutrophiles. Additionally, a combination of better techniques for rapid reperfusion and use of neutrophil inhibitors and anti-oxidants will help in reduction of the enormous cost associated with the clinical trials for treatment of reperfusion injury. Other options under study for treatment of reperfusion injury include hypothermia treatment, post conditioning such as mechanical and pharmacologic have shown success in few patients.

Larger experiments exploring the potential of various therapeutic options in order to influence clinically relevant endpoints are yet awaited for options which are currently insufficiently demonstrated in clinical use of these reperfusion injuries.

Reperfusion Injury Market: Companies Mentioned in the Report

Apeptico Forschung und Entwicklung GmbH, Eustralis Pharmaceuticals Ltd., NeuroVive Pharmaceutical AB, Nyken BV, Stealth Peptides, Inc., Scynexis, Inc., and Vasade Biosciences, Inc. are some of the key players contributing to the global reperfusion injury market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Reperfusion Injury Market 2016-2024 Growth and Forecast here

News-ID: 656821 • Views: 324

More Releases from Transparency Market Research

Cyclopentane Market to Reach US$ 533,319.84 Thousand by 2026
The global cyclopentane market was valued at US$ 284,460.87 Thousand in 2017 and is anticipated to expand at a CAGR of 6.6% from 2018 to 2026, according to a new report titled ‘Cyclopentane Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,’ published by Transparency Market Research (TMR). The global cyclopentane market is driven by rise in the demand for climate-friendly refrigerators from the consumer electronics industry. Europe
Electronic Adhesives Market to hit US$ 8,107.3 Mn by 2026
The vendor landscape of the global electronic adhesive market is highly competitive and packed with large number of players. Players are focusing towards the customization of the electronic adhesives as per different customer reqquiremnt, saya Transparancy Market Reseach. Some of the key players operating in the global electronic adhesive market are Henkel AG & Co. KGaA, Dow Chemical, HB Fuller, Kyocera Chemical Corp, 3M Company, Bondline Electronic Adhesives, Inc, Dymax
Automotive Refinish Coatings Market Worth US$ 13,231.44 Mn by 2026
The demand within the global automotive refinish coatings has been rising on account of advancements in automobile manufacturing. The need for manufacturing high-end vehicles, characterised by perfect finish and aesthetics, has given a thrust to market growth. Moreover, automobile manufacturers have established dedicated sections for repair, overhaul, and finetuning of automobiles. Therefore, the total volume of revenues within the global automotive refinish coatings market is slated to touch new values.
Global Analysis of Yogurt Market- Covid-19 Impact, Dynamics, Segments and Supply …
Yogurt is a diary product. Yogurt is produced by fermentation of milk by bacterial treatment. The bacteria in the presence of lactose in milk, produces lactic acid. The lactic acid produced by the bacterial treatment reacts with milk protein to impart the texture and taste of yogurts. Yogurt is generally produced from cows’ milk as it is readily available all across the world. Obtain Report Details @ https://www.transparencymarketresearch.com/yogurt-market.html Non-dairy yogurts

All 5 Releases


More Releases for Reperfusion

Reperfusion Injury Market Trends And Forecast 2016-2024
Reperfusion Injury Market: Description Reperfusion injury is referred to as the tissue damage caused due to absence of blood supply or lack of oxygen such as damage to brain after stroke or heart post episodes of ischemia. Such kind of restoration of blood supply results into inflammation and oxidative damage through the induction of oxidative stress rather than normal functioning. Confined infarct size and reduced mortality can be achieved by prompt
Reperfusion Injury Market to Register Substantial Expansion by 2024
Reperfusion Injury Market: Description Reperfusion injury is referred to as the tissue damage caused due to absence of blood supply or lack of oxygen such as damage to brain after stroke or heart post episodes of ischemia. Such kind of restoration of blood supply results into inflammation and oxidative damage through the induction of oxidative stress rather than normal functioning. Confined infarct size and reduced mortality can be achieved by prompt
Reperfusion Injury Market Global Analysis & 2024 Forecast Report
Reperfusion Injury Market: Description Reperfusion injury is referred to as the tissue damage caused due to absence of blood supply or lack of oxygen such as damage to brain after stroke or heart post episodes of ischemia. Such kind of restoration of blood supply results into inflammation and oxidative damage through the induction of oxidative stress rather than normal functioning. Confined infarct size and reduced mortality can be achieved by prompt
Reperfusion Injury Market: Growth, Opportunities and Advanced Technologies by 20 …
Reperfusion injury is referred to as the tissue damage caused due to absence of blood supply or lack of oxygen such as damage to brain after stroke or heart post episodes of ischemia. Such kind of restoration of blood supply results into inflammation and oxidative damage through the induction of oxidative stress rather than normal functioning. Confined infarct size and reduced mortality can be achieved by prompt restoration of blood
03-27-2017 | Health & Medicine
TMR
Reperfusion Injury Market - Advanced Technologies and Global Industry Analysis 2 …
Reperfusion injury is referred to as the tissue damage caused due to absence of blood supply or lack of oxygen such as damage to brain after stroke or heart post episodes of ischemia. Such kind of restoration of blood supply results into inflammation and oxidative damage through the induction of oxidative stress rather than normal functioning. Confined infarct size and reduced mortality can be achieved by prompt restoration of blood
Research Report explore the Global Reperfusion Injury Market
MarketResearchReports.Biz presents this most up-to-date research on "Reperfusion Injury-Pipeline Insights, 2017" Latest Report, Reperfusion Injury-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Reperfusion Injury. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing,